ViewRay rises on China approval for radiation therapy system

Viewray

07/09/2022 14:26

** Shares of ViewRay Inc  VRAY.O  gain ~3% to $3.35
premarket 
    ** Co says it has received approval from Chinese regulator
National Medical Products Administration for sale and
utilization of its MRIdian radiation therapy system in country
 urn:newsml:reuters.com:*:nPnB1Qj8a
    ** The systems helps in treatment of cancer by improving
targeting precision for higher and potentially more effective
radiation doses against tumors - Co
    ** As of last close, stock down 41% YTD

 (Reporting by Raghav Mahobe)
 ((Raghav.Mahobe@thomsonreuters.com;))